{"name":"Nuvig Therapeutics, Inc.","slug":"nuvig-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NVG-2089","genericName":"NVG-2089","slug":"nvg-2089","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"NVG-2089","genericName":"NVG-2089","slug":"nvg-2089","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOeV9fQ1N6dm5iSDRuSFFmNUtBWFZTTzg4MElPRzFCZ2dCVkJ0RU8yRkN4c0lLMHE4b1N2YUhlZENVbGMyNklVLWJNem1WUE5XSWpQVllWSFpyUUc2d3VPa3RiM2dhZkFYYThJUldZajBPTlVLNFVIVzl5bzBKSWVfSTJETi1jZVVmTVRIQUpFMjczUEVHVXhiQUplNWF1WTRxWUU1NGhyNERjNlFHMUJ2dTRwbHBfbE91a3JldTZFeUFJZ1dDN3cwWQ?oc=5","date":"2025-11-18","type":"pipeline","source":"businesswire.com","summary":"Nuvig Therapeutics Appoints Celia J.F. Lin, M.D., as Chief Medical Officer - businesswire.com","headline":"Nuvig Therapeutics Appoints Celia J.F. Lin, M.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPZWZmdEYtVlVNbTdNM0dFcVhYWU1SUFdRak0xd3JfZlF6Vk1Td2lod2ZmOTVxYkdZNkFTUDE1RDRzbHNCcmJFTjAtNC1CVnJlWjV4enp6V2p6dGNTQmg4ajRBZUpWVXQweHhhV0dfVjJlWG1HZEFMY0hIQ2pFdzBocUE4d1JfOGZjaGpMbW1QVWRxdw?oc=5","date":"2025-09-22","type":"pipeline","source":"Fierce Biotech","summary":"Introducing Fierce Biotech's 2025 Fierce 15 - Fierce Biotech","headline":"Introducing Fierce Biotech's 2025 Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9hSmFJZFhvUDNYUkVoSXB0bzRXckdvUVoxZXZHc2NiWnlZYjFrQ1JKWFlDMkRNZjNJZjdXYXhaUHRaN2dqbnd4U3d6SFVDYjJNOG55OWI0Y2RhbFcwdlhR?oc=5","date":"2024-12-10","type":"pipeline","source":"The Pharma Letter","summary":"Nuvig Therapeutics - The Pharma Letter","headline":"Nuvig Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9iSXdqT2tUbkt2WUFTYUxWNVB3WjBHUlpwdmNyUDZQR0Y1ZGtaU1pFYnRGellrckotaVViVGFQdVhNTXJic3JCR1VMZkF0VXBSeTJqQ1Q4M3FMTEwtYVZOU3JnSzg3RWhPbFFMWWRvWQ?oc=5","date":"2024-12-06","type":"pipeline","source":"medwatch.com","summary":"Novo Holdings invests an additional USD 161m in US biotech company - medwatch.com","headline":"Novo Holdings invests an additional USD 161m in US biotech company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQQ2M2MFF0ZUNTaVFUcXBKNkRXVUpLRHNrVmdBcV90TXc5OGZsTEtSLURGazBVb1BwbVhqa19Majdqd3Y0Wm1peDhKTGt2U2FIeTRjZTMtNnVQWFJPY3g4cjdTaGdvd18tMG5OeVczczhJbHdKZ1I3a0U3VUpacWtFb0RSQlU3UlpETUtoNzU4Tm1JOFg5SDB4am5QUFZYdFkxZ2M2Z0JBTWVGa0xD?oc=5","date":"2024-12-05","type":"trial","source":"Fierce Biotech","summary":"Sanofi-backed Nuvig marches lead autoimmune therapy into phase 2 with $161M series B - Fierce Biotech","headline":"Sanofi-backed Nuvig marches lead autoimmune therapy into phase 2 with $161M series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOTUREMk5TaVNMMmdPMXRmbmJ1N0tmWHhIUVpMSXZRSl9YRlpHMEI2RW1rOXphZllpNVlNLWw0ak9oQWlRVTl1aDNUN0Vvc0k2SFc3aDh0Vm4xelNIRk1meXdQNXRHMmVsVTJkWDJ4NVZ6Y3gyelA2UldsLW1FcHd4VEVJbVB5Q1VWWWo4ejA2eU1XS21wTTZ3NnFJSGtKYWxiaW40Y2N0cTRoLWVVLVR5Y0Iybw?oc=5","date":"2024-12-05","type":"pipeline","source":"BioSpace","summary":"Nuvig Ropes in $161M Series B From Big Pharma Players for Autoimmune Indications - BioSpace","headline":"Nuvig Ropes in $161M Series B From Big Pharma Players for Autoimmune Indications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUEZpbEs5d2lvd1JKUEY1MDBfMENrcWZVZklSQmdYWFc3VlU4anl2MURSZnhNUFUxbEVOOGNBX2czWmhZMUtUWU1BbVgzdFFFd0JYRnJ2ejk5QllPTGNWOFFLd3ZVOFl5dXl2b0x0dUdDRUk5ZHhWZnVudmc3TGVXX1k3UllfSWI4Mnhub3VB?oc=5","date":"2024-12-05","type":"pipeline","source":"BioPharma Dive","summary":"Nuvig pulls in $161M to make better immune drugs - BioPharma Dive","headline":"Nuvig pulls in $161M to make better immune drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxPLU1scU1OWEQxeXNlZEFRbFhoNXY2Z2F1bllWTS1HX3JLcFlONm5hNnNlS2VPSndPMmJockNjakxXOVFQejRuNzFkcTJTMjdCOGN6Z29KZTJHVnpMRXlKdVhfU2JXVUxzZ1lUemU4U1dGZy1GTGZZOFZFREJzazVZa1V5TjZzamZ6Rko1T1dFLTRkODRWZG9iTG12Rnh6eUpxYUVGRlM1Yk5CWm55dnM2b2pCbWloYl9OX19IeDVLdmhqRGJtdVVsMWpSRFE4NXhseE50ckFXSnAtWFZJN0lVNU0tWFNnWmR1OXktbjUzVkRoVVA3RXJCLWt2X3Job1Z4ZnExWFk3WFpfeTE5anF6cF9mWXA3SXkyYnNkMkVWN0lvazhHa3FLUzdYRQ?oc=5","date":"2024-12-05","type":"trial","source":"businesswire.com","summary":"Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator - businesswire.com","headline":"Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-G","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQdzhuUXctNE9uYVlGMUpUU1Y0cUJ0bmZqUlUxLVVTVm9kRnR6czdVNV9TQUVfUHEzLVN2clk2dzQyOU9fbHJSeGVRYlVxUGE1Y1MzYnRfZXNYZ0FFRURnaFRXeDB6emtHU2xDOUZpcTZTZmxQMUhwd2NzdHVnWUlZY0h1andhc0VMWFdNTmdiaHVwZlRheHJyeERIUGctUnJpNmdwMFlMY3ZfMVNLWE5uTEFlVzFPVWgtWHNMUg?oc=5","date":"2022-05-11","type":"pipeline","source":"Fierce Biotech","summary":"Inflammation space swells further as Nuvig unveils $47M to transform autoimmune therapies - Fierce Biotech","headline":"Inflammation space swells further as Nuvig unveils $47M to transform autoimmune therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQNWJ6UHBFUkdkcjVEQUt2blozMXRpWnpqcUlMRjkwSkFWNlgyNFJjTmlxR0FNMHJJcFZnZlNic1NWUzFrQXkyaFBCSndpT0xleHpULTVVOFM5RHJ6cTRiNlpvWm1HZTRLR09LYzhZLWJWSGVtQ0FMNmhDMjFlLVRiNU5KR1pndWI4VkdwYmhuMkdJVW9CV3NwdTNUeGFKMmx6a0ZDVFJqUEFpNjU2UHVJMV9pNE84c00tWlk3cnVjb2U0b3h3QmVnejhZYVFKbWFpOGJwVnR2aDlWNU1nVG0yblBhSjM1YTRfZmM1QThB?oc=5","date":"2022-05-11","type":"pipeline","source":"businesswire.com","summary":"Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases - businesswire.com","headline":"Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}